Delivery Order SPE2DB24D8002-SPE2DB24FJNAD

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ORENCIA 125 MG/ML syringes. The $5,004.06 firm-fixed-price contract has an ultimate completion date of October 31, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a significant single-award Indefinite...
The Defense Logistics Agency (DLA) awarded a $3,765.27 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Orencia ClickJect 125 mg/ml autoinjectors. This order is part of a larger $999,999,999.00 indefinite delivery contract (SPE2DB24D8001) held by Dakota Drug with DLA Troop Support Medical for a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces...
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2UQ0, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Orencia 125 mg/ml syringes. The contract is a firm-fixed-price Delivery Order with a ceiling value of $10,460.93 and a completion date of January 23, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The award, valued at $10,206.57, is for the delivery of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. This contract has a performance period extending through September 20, 2023 and is a firm fixed-price delivery order with no set-aside designation. Dakota Drug, Inc. holds a significant single-award Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business. The contract is for the delivery of Orencia 125 mg/ml syringes, a pharmaceutical product. The contract has a firm fixed price of $7,098.20 and a period of performance extending to March 10, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, that allows the company to provide a range of...
This federal contract award, identified as SPE2DB24D8002|SPE2DB24FJMQJ, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,662.00 Firm Fixed Price Delivery Order is for the pharmaceutical product ORENCIA 125 MG/ML SYRINGEML. The award is not associated with a set-aside program and has an ultimate completion date of July 23, 2024. Dakota Drug, Inc. has an existing Indefinite Delivery Contract (IDC) with the DLA, contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Orencia ClickJect 125 mg/mL pharmaceutical product. The firm-fixed-price contract has a ceiling value of $15,712.57 and a performance period extending through December 4, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $5,132.04, is for the provision of Orencia ClickJect 125 mg/ml, a pharmaceutical product. The award is not designated as a set-aside contract. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as...
This is a $23,856.51 firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) to provide Orencia Clickject 125 mg/ml medication. The delivery order has a completion date of July 10, 2024. Dakota Drug, Inc. is an experienced federal contractor that has supplied a wide range of pharmaceutical products and medical supplies to the DLA Troop Support Medical for over two decades. This delivery order does not have...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYUQ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $10,348.93, is for the delivery of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. This contract is part of the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug,...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB24FJNAD
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $6,192.13 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of ORENCIA 125 MG/ML syringes. This award is under Dakota Drug, Inc.'s existing $999,999,999.00 Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment. The contract has an ultimate completion date of September 25, 2024. Dakota Drug, Inc. is a key supplier for the DLA's military medical supply programs, providing a wide range of critical pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations.

Generated 12/24/24, 9:20 AM